In our August issue of Pharmaceutical Executive FEATURES
Emerging Biopharma The Big Apple's Fresh Start in Biotech Michelle Maskaly
Though challenges in space and affordability remain, New York City is emerging as a hotspot for biotech incubators, including one startup whose CEO made the career leap from big pharma to forging new discoveries in medical science.
Emerging Biopharma Innovation, Location, and Inspiration Lisa Henderson
Examining the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
Emerging Biopharma Biotech Investment: Reigning in Spain Julian Upton
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Globalization The State of Cross-Border Funding in the Life Sciences James Leech
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
Dealmaking The Pulse of Biopharma M&A Michelle Maskaly
New trends report spotlights the promise and cautions for prospective life sciences dealmakers.
ALSO IN THIS ISSUE
From Science to Success Lisa Henderson
A common thread in our exploration of "Emerging Biopharma" is that these companies need to be those that look beyond pure discovery—and put equal effort into the pivot to potential commercialization …Read more